Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of tDCS in Fibromyalgia: A Controlled Clinical Trial and Analysis of Electrophysiological Biomarker Predictors.

NCT07583056 is registered in ClinicalTrials.gov with Ionclinics & Deionic SL as lead sponsor.

NCT NCT07583056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07583056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of tDCS in Fibromyalgia: A Controlled Clinical Trial and Analysis of Electrophysiological Biomarker Predictors.
Lead sponsor
Ionclinics & Deionic SL
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2026
Completion date
June 30, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia (fm)